Express Scripts Holding Company (NASDAQ:ESRX) shares increased 0.70% in last trading session and ended the day at $84.49. ESRX Gross Margin is 8.30% and its has a return on assets of 4.20%. Express Scripts Holding Company (NASDAQ:ESRX) quarterly performance is -3.34%.
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. The company’s PBM segment’s services include clinical solutions to enhance health outcomes, such as adherence, case coordination, and personalized medicine; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration.
On 10 September, Express Scripts Holding Company (NASDAQ:ESRX) named health-care sector veteran Eric Slusser as its chief financial officer. James M. Havel, who has been financial chief on an interim basis for roughly eight months, will stay with Express Scripts as a finance executive to assist with the transition.
Plug Power Inc. (NASDAQ:PLUG) ended the last trading day at $1.70. Company weekly volatility is calculated as 4.52% and price to cash ratio as 2.70. Plug Power Inc. (NASDAQ:PLUG) showed a weekly performance of 0.59%.
Plug Power Inc. is a provider of alternative energy technology focused on the design, development, commercialization and manufacture of hydrogen fuel cell systems used for the industrial off-road market and the stationary power market. The Company’s product line includes GenKey, GenDrive, GenFuel, GenCare and ReliOn. GenKey offers solutions to customers transitioning their material handling vehicles to fuel cell power. GenDrive is a hydrogen fueled PEM fuel cell system. It provides power to material handling vehicles.
On 11 September, Plug Power Inc. (NASDAQ:PLUG), the Latham fuel cell manufacturer, completed its first transaction in Europe with a company called Prelodis, which operates a retail food warehouse in France.
The Dow Chemical Company (NYSE:DOW) shares increased 0.05% in last trading session and ended the day at $43.78. DOW Gross Margin is 20.30% and its has a return on assets of 5.90%. The Dow Chemical Company (NYSE:DOW) quarterly performance is -14.88%.
The Dow Chemical Company (Dow) is as an integrated science and technology company. The Company is a diversified, manufacturer and supplier of products used primarily as raw materials in the manufacture of customer products and services across the world. The Company operates in five segments: Agricultural Sciences, Consumer Solutions, Infrastructure Solutions, Performance Materials & Chemicals and Performance Plastics.
The Dow Chemical Company (NYSE:DOW) declared a dividend of 42 cents per share, payable Oct. 30, to shareholders of record on Sept. 30. This marks the 416th consecutive cash dividend issued by the Midland-based company, according to a company news release. Dow has paid its shareholders cash dividends every quarter since 1912.
Advanced Micro Devices, Inc. (NASDAQ:AMD) caters to the Technology space. It has a net profit margin of -15.30% and weekly performance is 12.29%. On the last day of trading company shares ended up $2.01. Advanced Micro Devices, Inc. (NASDAQ:AMD) distance from 50-day simple moving average (SMA50) is 5.48%.
Advanced Micro Devices, Inc. is a global semiconductor company with facilities across the world. The Company offers x86 microprocessors, as standalone devices or as incorporated as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs) and professional graphics, and server and embedded processors, dense servers, semi-custom System-on-Chip (SoC) products and technology for game consoles.
On 9 September, Advanced Micro Devices, Inc. (NASDAQ:AMD) announced the promotion of Raja Koduri (47) to senior vice president and chief architect, Radeon Technologies Group, reporting to president and CEO Dr. Lisa Su. In his expanded role, Koduri is responsible for overseeing all aspects of graphics technologies used in AMD’s APU, discrete GPU, semi-custom, and GPU compute products.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) caters to the Healthcare space. Its weekly performance is -7.31%. On the last day of trading company shares ended up at $4.69. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) distance from 50-day simple moving average (SMA50) is -36.75%.
Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development of products for the treatment of renal diseases. Its lead product Auryxia (ferric citrate), an oral, absorbable iron-based compound, received marketing approval from the United States Food and Drug Administration (FDA), for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
Equities research analysts at Raymond James started coverage on shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) in a research report issued on Wednesday, The Fly reports. The brokerage set a “market perform” rating on the biopharmaceutical company’s stock.
Leave a Reply